ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1011

Single Cell RNA Sequencing of Patients with Psoriatic Disease

Rohan Machhar1, Kun Liang 2, Remy Pollock 1 and Dafna Gladman 3, 1Krembil Research Institute, University Health Network, Toronto, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Krembil Research Institute, U of Toronto, Toronto, ON, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: biomarkers and Gene Expression, psoriasis, Psoriatic arthritis, single cell sequencing

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Delayed diagnosis of psoriatic arthritis (PsA) can lead to poor clinical outcomes. A large proportion of PsA patients remain undiagnosed due to a lack of robust biomarkers. Gene expression analysis at single peripheral blood mononuclear cell (PBMC) resolution may help to identify novel cells and RNA signatures present in PsA compared to psoriasis patients without arthritis (PsC).

Methods: PBMCs were isolated from 3 patients with early PsA (< 2 years) and 3 PsC patients matched for age, sex, and psoriasis duration. All patients were treatment naïve. Single cells were isolated using the droplet-based Chromium platform (10X Genomics) and cDNA libraries were sequenced on an Illumina HiSeq 4000. Data were processed in CELLRANGER and secondary analysis performed using R packages. Poor quality cells were filtered out based on high percentage of mitochondrial content, number of genes expressed and library size. Data were normalized by scran normalization and unsupervised graph-based clustering of cells was performed using a K-nearest neighbor algorithm. Cell types were inferred using immune marker genes and computed cluster markers.

Results: PsA patients were 2/3 male, median age 65 (range 53-75) years, median active joint count 3 (0-7), and median psoriasis area and severity index (PASI) score of 1.4 (0.4-3.1). PsC patients were 2/3 male, age 64 (56-75) years, PASI score 2.8 (0.3-8.7). After quality control and filtering, high quality expression profiles were obtained from 7350 and 7022 cells from PsA and PsC patients, respectively. The number of clusters identified in each sample is shown in Table 1. Sample PsA2 had unique clusters of monocytes and CD34+ cells, whereas PsC2 had a unique cluster of plasmacytoid dendritic cells. The remaining clusters were evident in all patients and consisted of T cells, B cells, macrophages, NK cells and myeloid dendritic cells. Differential expression analysis of PsA compared to PsC patients revealed several differences (shown in Table 2). In myeloid dendritic cells significant upregulation of genes such as JUP (junction plakoglobin/gamma catenin, fold change[FC]=1.36, adj.p=6.8×10-47) and LYZ (lysozyme, FC=1.23, adj.p=2.9×10-39) was found. T cells showed significant downregulation of IL32 (interleukin 32, FC=0.66, adj.p=5.0×10-35), ERAP2 (endoplasmic reticulum aminopeptidase 2, FC=0.77, adj.p=3.0×10-16), and upregulation of HLA-C (human leukocyte antigen C, FC=1.28, adj.p=3.2×10-33). FCGR3A+ monocytes showed a significant upregulation of IFITM3 (interferon induced transmembrane protein 3, FC=1.56, adj.p=3.5×10-11) and LILRA6 (leukocyte immunoglobulin-like receptor A6, FC=1.23, adj.p=1.8×10-5). Cytotoxic T cells showed upregulation of TRBV4-2 (T cell receptor beta variable 4-2, FC=3.02, adj.p=7.3×10-29) and TNFAIP3 (TNF alpha induced protein 3, FC=1.35, adj.p=3.8×10-6). Natural killer cells and naïve T helper cells showed significant downregulation of several ribosomal proteins in PsA compared to PsC patients.

Conclusion: The data show novel insights into gene expression differences in different cell populations that might help in differentiating PsA from PsC.


Table 1

Table 1. Number of clusters identified in each sample.


Table 2

Table 2. Top 5 differentially expressed genes across selected cell types.


Disclosure: R. Machhar, None; K. Liang, None; R. Pollock, None; D. Gladman, None.

To cite this abstract in AMA style:

Machhar R, Liang K, Pollock R, Gladman D. Single Cell RNA Sequencing of Patients with Psoriatic Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/single-cell-rna-sequencing-of-patients-with-psoriatic-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-sequencing-of-patients-with-psoriatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology